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Abstract
The Mycobacterium abscessus complex is an emerging cause of chronic pulmonary infection in patients with underlying
lung disease. The M. abscessus complex is regarded as an environmental pathogen but its molecular adaptation to the
human lung during long-term infection is poorly understood. Here we carried out a longitudinal molecular epidemiological
analysis of 178 M. abscessus spp. isolates obtained from 10 cystic fibrosis (CF) and 2 non CF patients over a 13 year period.
Multi-locus sequence and molecular typing analysis revealed that 11 of 12 patients were persistently colonized with the
same genotype during the course of the infection while replacement of a M. abscessus sensu stricto strain with a
Mycobacterium massiliense strain was observed for a single patient. Of note, several patients including a pair of siblings were
colonized with closely-related strains consistent with intra-familial transmission or a common infection reservoir. In general,
a switch from smooth to rough colony morphology was observed during the course of long-term infection, which in some
cases correlated with an increasing severity of clinical symptoms. To examine evolution during long-term infection of the CF
lung we compared the genome sequences of 6 sequential isolates of Mycobacterium bolletii obtained from a single patient
over an 11 year period, revealing a heterogeneous clonal infecting population with mutations in regulators controlling the
expression of virulence factors and complex lipids. Taken together, these data provide new insights into the epidemiology
of M. abscessus spp. during long-term infection of the CF lung, and the molecular transition from saprophytic organism to
human pathogen.
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Introduction
The Mycobacterium abscessus complex is a group of rapidly
growing mycobacteria (RGM) that is associated with an array of
human infections typically affecting the lungs, skin or soft tissues
[1–4]. Chronic lung infection is most frequently observed in
patients with underlying lung disease, especially those suffering
from cystic fibrosis (CF) [5,6], and M. abscessus spp. infections in
CF patients are linked to disease progression [2]. M. abscessus
complex is subdivided into the 3 species M. abscessus sensu stricto,
Mycobacterium massiliense and Mycobacterium bolletii which exhibit
clinically relevant differences in antibiotic sensitivity profile [7–9].
Chronic infections caused by environmental pathogens are
characterized by the ability of the infecting organisms to adapt to a
very different niche habitat, leading to changes in phenotype
influencing colony morphology, inflammatory response, and
antibiotic resistance [10–12]. Like other RGM the M. abscessus
spp. are saprophytic organisms associated with water reservoirs
linked to human activity [13,14]. M. abscessus sensu stricto is innately
resistant to many classes of antibiotic [15] and readily acquires
resistance to clarithromycin during infection [16]. In addition, M.
abscessus sensu stricto exhibits differences in colony morphology
including smooth colony variants typical of environmental and
early infection isolates [6] which are replaced over a period of
years with rough variants capable of invasion of macrophage and
respiratory epithelial cells, and associated with severe inflamma-
tion [17,18]. Previous studies have demonstrated the long-term
persistence of single M. abscessus spp. strains during chronic
infection of the CF lung with occasional sharing of strains between
sibling pairs, implying that transmission between patients may
occur [19]. A recent study provided evidence for an outbreak
involving M. massiliense infection of 5 patients attending a CF clinic
implying that some strains of M. abscessus complex may have
epidemic potential [1].
The phenomenon of long-term persistence of M. abscessus
complex during chronic infection of the human lung is well
established. However, the relative prevalence of the 3 M. abscessus
species among long-term infected patients, and the capacity of M.
abscessus complex to transmit between patients have not been well
examined. Here, we carry out longitudinal molecular tracking of
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M. abscessus complex isolates from chronically infected patients
with multi-locus sequence and PCR-based bacterial typing. We
also combine whole genome sequencing of sequential isolates with
phenotypic analysis of colony morphology and antibiotic sensitiv-
ity to examine the adaptive diversification of M. abscessus spp.
during chronic infection of the human lung revealing a genetically
and phenotypically heterogeneous infecting population. In addi-
tion, the data provide molecular correlates of adaptation of M.
abscessus spp. to the human lung that will inform future studies
investigating M. abscessus pathogenesis.
Materials and Methods
M. abscessus Complex Isolates and Culture Conditions
All clinical isolates were referred to the Scottish Mycobacteria
Reference Laboratory (SMRL) for identification, susceptibility
testing, DNA extraction and long-term storage. Ethical approval
for use of samples/data was provided by the National Health
Service, South East of Scotland HSS BioResource facility
operating within the Tissue Act Scotland 2006. The Scientific
Officer indicated that the research does not need NHS ethical
review under the terms of the Governance Arrangements for
Research Ethics Committees (A Harmonised Edition). In partic-
ular, research limited to secondary use of information previously
collected in the course of normal care (without an intention to use
it for research at the time of collection) is generally excluded from
REC review, provided that the patients or service users are not
identifiable to the research team carrying out the research. The
review board waived the need for written informed consent from
the participants.
A total of 178M. abscessus spp. pulmonary isolates were obtained
from 12 patients in Scotland between 1998 and 2010, including 10
unrelated patients and 1 sibling pair. Annual incidence of M.
abscessus spp. infection is estimated at ,887/100,000 in Scottish
cystic fibrosis patients or about 8 patients annually (Scottish
Mycobacterium Reference laboratory, data not shown). Of the 12
patients, 10 suffered from cystic fibrosis and 2 had significant co-
morbidities including cirrhotic alcoholic liver disease, and acute
myeloid leukemia, both with chronic pulmonary disease (Table 1).
The mean age at first isolation of M. abscessus amongst the CF
patients was 15 y (range 12–23 y). One CF patient successfully
cleared carriage and went on to lung transplantation. Isolates were
identified as M. abscessus spp. by GenoType Mycobacterium CM
test (HAIN Lifescience, Germany). Species type strains included
M. abscessus NCTC 13031, M. bolletii DSM 45149 and M.
massiliense DSM 45103. Isolates were cultured on Loewenstein
Jensen egg slopes or Columbia Horse Blood Agar (Oxoid,
Hampshire, UK) statically at 37uC.
Genomic DNA Extraction
Genomic DNA (gDNA) was extracted from bacteria following
the method described by van Soolingen et al. [20] and previously
used for M. abscessus spp. [21]. DNA yield was quantified using a
Nanodrop ND-1000 Spectrophotometer (Thermo Scientific,
USA).
ERIC-PCR Typing
For ERIC-PCR, 50 ml reactions included 2 mM forward and
reverse oligonucleotide primers described by Sechi et al. [22],
0.25 U of Go-Taq Flexi DNA Polymerase, 5x Green Go Taq Flexi
Buffer, 1.5 mM MgCl2, 200 mM dNTPs (Promega, Hampshire,
UK) and 10 ng approx. gDNA. Thermocycling conditions were
3 min at 95uC followed by 30 cycles of 95uC for 1 min, 55uC for
1 min and 72uC for 5 min with a final extension of 10 min at
72uC. Agarose gel electrophoresis of ERIC-PCR products was
followed by comparative analysis of resolved profiles with the
BioNumerics program v5 with clustering by UPGMA with Dice
similarity. Independent genomic DNA extractions resulted in
indistinguishable ERIC-PCR profiles, demonstrating the method
to be highly reproducible (data not shown).
Figure 1. Genotypic analysis of M. abscessus spp. isolates from persistently infected patients. Dendrogram constructed using
BioNumerics showing the genetic relatedness among ERIC-PCR profiles of 1 representative isolates from each of the 12 patients.
doi:10.1371/journal.pone.0063237.g001
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Multi-locus Sequence Typing (MLST)
MLST was carried out as described previously [9]. Briefly, 50 ml
PCR reactions specific for the 7 housekeeping loci included
0.2 mM forward and reverse oligonucleotide primers, 0.25 U of
Go-Taq Flexi DNA Polymerase, 5x Green Go Taq Flexi Buffer,
1.5 mM MgCl2, 200 mM dNTPs (Promega, Hampshire, UK) and
10 ng approx. gDNA. Thermocycling conditions were 3 min at
95uC followed by 30 cycles of 95uC for 1 min, 55u–60uC for 1 min
and 72uC for 1 min with a final extension of 10 min at 72uC.
Sequencing was carried out by The GenePool Sequencing Service
(King’s Buildings, University of Edinburgh, UK), and sequences
assembled using Geneious 5.4.2. [23]. Alleles and sequence types
were determined using the Institute Pasteur M. abscessus MLST
database (http://www.pasteur.fr/recherche/genopole/PF8/mlst/
references_abscessus.html). Single and multi-gene phylogenies
were re-constructed using a neighbor-joining method with the
HKY model of nucleotide substitution, with support for nodes
assessed by 1000 bootstrap replicates.
Whole Genome Sequencing and Analysis
Whole genome sequencing was carried out with the Illumina
GA2 sequencing platform. The FASTX toolkit [24] was used to
assess read quality, remove adaptor sequences, remove 3 bp from
the 59 end of the read and filter reads so that at least 80% of bases
within a read were of PHRED score Q30 or above. Paired-end
reads were mapped to a draft genome sequence of M. bolletii [25]
using the BWA short read aligner [26]. Polymorphic sites were
identified at loci covered by at least 3 reads where the alternative
base was present in at least two thirds of the reads with PHRED
equivalent score greater than 30, and inspected manually. As an
additional confirmation, reads were mapped to the genome of M.
abscessus sensu stricto strain ATCC 19977 (accession number
CU458896), and only those variants present in both reference
genomes are reported. A neighbor-joining phylogeny was recon-
structed based on the polymorphic sites identified using the HKY
substitution model. 1000 bootstrap replicates were used to
determine support for key nodes.
Antibiotic Susceptibility Testing
MICs of amikacin, amoxicillin/clavulanic acid, cefepime,
cefoxitin, ceftriaxone, ciprofloxacin, clarithromycin, doxycycline,
imipenem, linezolid, minocycline, moxifloxacin, tigecycline, to-
bramycin, trimethoprim/sulphametoxazole were determined by
the Clinical and Laboratory Standards Institute recommended
micro-dilution method in Mueller-Hinton broth using Sensititre
RGMYCO plates (TREK Diagostics, USA). Plates were incubat-
ed at 37uC and successive readings were taken after 5, 6, 8, 9, 12
and 14 d of incubation.
Figure 2. Phylogenetic reconstruction (MLST) resolves the species designation of each M. abscessus spp. isolate. Neighbour-joining
tree of 13 clinical isolates and type strainsM. abscessus NCTC 13031, M. bolletii DSM 45149 and M. massiliense DSM 45103 based on four concatenated
MLST gene sequences (argH, glpK, gnd and murC). Colour coding indicates M. abscessus sensu stricto (red), M. bolletii (blue) and M. massiliense (green)-
associated clades. Bootstrap support for significant branches is indicated, and branch lengths are representative of substitutions per site.
doi:10.1371/journal.pone.0063237.g002
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Results and Discussion
Molecular Population Genetic Analysis of M. abscessus
spp. from Chronically Infected Patients
In order to examine the long-term persistence of M. abscessus
spp. during infection of the human lung, we analyzed a total of 178
sequential M. abscessus complex isolates from 12 patients and
carried out multi-locus sequence type (MLST) analysis of each
unique ERIC-PCR genotype identified in each patient. ERIC-
PCR has been shown to be highly discriminatory for grouping
outbreak strains of M. abscessus spp. and does not suffer from
problems of degradation that occur with some electrophoresis-
based methods [21]. In total, 12 genotypes representing 9 distinct
sequence types (ST), including 6 novel STs and 3 M. abscessus
complex species, were identified among the 12 patients (Fig. 1;
Table 1). For 11 of 12 patients, a single genotype was identified
during long-term infection (2 to 12 years) consistent with persistent
Figure 3. Evolutionary genomic analysis of M. bolletii during a 12 year chronic infection of a single CF patient. (A) Schematic
representation of the timescale of infection including isolation dates of smooth colony phenotype (circles), rough colony phenotype (triangles), and
sequenced isolates (filled symbols), respectively. Approximate time periods of antibiotic treatment are indicated by arrows. (B) Neighbor-joining
phylogenetic tree of M. bolletii isolates from a single patient based on core genome SNPs.
doi:10.1371/journal.pone.0063237.g003
Table 2. Isolates from patient 1 selected for whole genome
sequencing.
Specimen
date Colony morphology
MIC Clarithromycin
(mg/l)
ED1-1 1998 Smooth .16
ED1-2 1998 Smooth .16
ED1-3S* 2006 Smooth .16
ED1-3R* 2006 Rough .16
ED1-4S* 2009 Smooth .16
ED1-4R* 2009 Rough .16
*Isolates 3S/R and 4S/R were obtained from the same specimen.
doi:10.1371/journal.pone.0063237.t002
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infection with the same strain. In contrast, for patient 9, the first 5
chronological isolates exhibited a genotype that was distinct from
that of the subsequent seven isolates suggesting replacement of the
original infecting strain during the course of infection (Fig. 1).
Table 3. Genome variation among sequential M. bolletii isolates from a single patient.
*Type of mutation in isolates:
Gene Product ED1-1 ED1-2 ED1-3R ED1-3S ED1-4R ED1-4S
Arabinosyltransferase C NS NS NS NS
Prephenate dehydrogenase NS
Amine oxidase NS
Glutamate-cysteine ligase GshA NS NS NS NS
Sensor histidine kinase PhoR NS NS NS
Putative YrbE family protein NS
Fatty-acid-CoA ligase FadD NS
Putative alkanesulfonate monooxygenase STOP STOP
Oxidoreductase S
Indole-3-glycerol-phosphate synthase NS
Acetolactate synthase S
50S ribosomal protein L14 NS
Ribonuclease III NS NS
Cytochrome P450 NS
Glycosyltransferase GtfA NS
*Type of mutation in isolates:
Gene Product ED1-1 ED1-2 ED1-3R ED1-3S ED1-4R ED1-4S
Hydrogen peroxide-inducible activator NS NS
Putative monooxygenase NS
Luciferase-like monooxygenase S
Oxalate decarboxylase NS
PPE family protein NS NS
23S ribosomal RNA NS
Transcriptional regulatory protein NS
Transcriptional regulatory protein S S S S
Hypothetical protein NS
Hypothetical protein STOP
Hypothetical protein S
Intergenic NCS NCS NCS NCS
Intergenic NCS NCS NCS NCS
Intergenic NCS NCS
Intergenic NCS
Intergenic NCS
Intergenic NCS NCS
*Type of mutation in isolates:
Gene Product ED1-1 ED1-2 ED1-3R ED1-3S ED1-4R ED1-4S
Hypothetical protein FSD FSD
Hypothetical protein FSD
Putative aminotransferase FSI
Hypothetical protein FSI
Intergenic NCI NCI NCI NCI
*NS, non-synonymous SNP; S, synonymous SNP; NCS, non-coding SNP; FSI, frameshift insertion; FSD, frameshift deletion; NCI, non-coding insertion.
doi:10.1371/journal.pone.0063237.t003
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MLST analysis of the isolates from patient 9 revealed that an M.
abscessus sensu stricto strain was replaced by an M. massiliense strain
(Table 1). Our findings are in agreement with other studies that
compared sequential M. abscessus isolates from CF patients
highlighting the long-term persistence of M. abscessus, and its
treatment-refractory nature [6,27,28]. However, the data indicate
for the first time that replacement of M. abscessus by unrelated
strains may occur during chronic infection.
M. massiliense ST23 is Prevalent among CF Patients
Single gene trees based on argH, glpK, gnd or murC sequences
exhibited 3 distinct clades that co-segregate with the type strains
M. abscessus NCTC 13031, M. massiliense DSM 45103 and M.
bolletii DSM 45149 (Fig. S1 in File S1). In contrast, the trees
constructed with cya, pta and purH sequences have topologies that
imply horizontal transfer of these alleles among the M. abscessus
complex. Of note, substantial horizontal gene transfer between
members of the M. abscessus complex has previously been
demonstrated [9]. Phylogenetic reconstruction based on the
concatenated sequences of the 4 MLST loci that did not display
evidence of horizontal transfer resulted in a tree with 3 well-
supported clades, each including one of the M. abscessus species
type strains (Fig. 2), facilitating species designation for the clinical
isolates. Of the 12 patients, 4 were infected with M. abscessus sensu
stricto, 5 with M. massiliense, 2 with M. bolletii and 1 (patient 9) was
infected with M. abscessus sensu stricto initially followed by
replacement with M. massiliense (Fig. 2; Table 1). Although a
number of studies have reported a higher prevalence of M.
abscessus sensu stricto among clinical isolates [8,29], Zelazny et al.
reported that M. massiliense was most frequently isolated from the
airways of young patients with an underlying lung disease [30].
Notably, 5 of 6 M. massiliense isolates belonged to ST23 which is
highly prevalent in the M. abscessus MLST database and has been
reported in France, Germany, Switzerland and an outbreak of skin
and soft tissue infections in Brazil. The finding that a single
sequence type is associated with disease in distant countries is
noteworthy and could indicate limited clonal variation among M.
massiliense strains. Alternatively, ST23 may represent a M.
massiliense subtype with enhanced pathogenic potential, or the
capacity to resist aggressive antibiotic treatment.
In the current study, isolates (ED2 and ED12) obtained from a
pair of siblings had closely-related genotypes of the same ST23,
consistent with a common infective source or cross infection
(Fig. 1). Of note, a recent study reports the likely transmission of
M. abscessus spp. between patients [1]. Furthermore, M. abscessus
spp. have been reported to occur in hospital water distribution
systems and clusters of infections have previously been linked to
contaminated bronchoscopes [31,32]. Huang et al. typed M.
abscessus spp. isolates from clinical and environmental sources
linking some infections to M. abscessus spp. present in water
distribution systems but the possibility of patient-to-patient
transmission could not be excluded [33].
Transition from Smooth to Rough Colony Morphology
during Chronic M. abscessus spp. Infection
Previous studies have reported a correlation between a switch in
smooth to rough colony morphology and an increase in virulence
[34]. In order to determine if M. abscessus spp. undergo changes in
colony morphology during long-term infection, the colony
phenotype of all isolates was examined. In 5 patients, the majority
of earlier isolates in these patients had a smooth colony
morphology with a small number of isolates demonstrating a
rough colony phenotype. However, over several years of persistent
infection, there was an increase in the proportion of isolates with a
rough colony morphology leading to uniformly rough colony
morphology for the later stage isolates (Table 1, Table S2 from
File S2). From patient 1, persistently infected with M. bolletii, 21 of
25 isolates obtained between 1998 and 2005 demonstrated raised,
moist, smooth colonies. The remaining four isolates, all collected
between 2006 and 2009, contained a mixture of smooth and rough
colonies. The timing of the emergence of rough colony phenotype
isolates from patient 1 correlates with an increase in severity of
clinical disease that was observed in 2005. The transition in colony
phenotype has been linked to an increase in severity of infection as
the rough phenotype induces an elevated inflammatory response
in the host [34]. It is feasible that in the patients with rough colony
isolates only, the M. abscessus infection was asymptomatic until a
smooth to rough colony phenotype switch resulted in elevated
inflammation and clinical symptoms.
Susceptibility of M. bolletii to Antibiotics during Long-
term Infection of a Single Patient
In order to examine the antibiotic sensitivity of M. abscessus spp.
isolates during long term infection of the CF lung in a patient
undergoing defined antibiotic treatment regimens, we examined 6
M. bolletii isolates obtained sequentially from a single patient
(Patient 1) over a 12 year period. She had received multiple
courses of antimicrobials over 12 years following deterioration in
her pulmonary function including a combination of ethambutol,
rifampicin and clarithromycin, and had previously been treated
with amikacin (Fig. 3). The patient was turned down for lung
transplantation in view of M. abscessus spp. culture-positivity.
Subsequently, the patient was treated with nebulized interferon
gamma but was again turned down for transplantation due to
extensive pleural disease. In June 2011, she had advanced cystic
fibrosis requiring ambulatory oxygen and was taking ethambutol,
rifampicin, clarithromycin, moxifloxacin, cotrimoxazole and
nebulised colistin. Amoxicillin/clavulanic acid, cefepime, cipro-
floxacin, doxycycline, minocycline, moxifloxacin, tobramycin and
trimethoprim/sulphamethoxazole demonstrated no activity
against any of the isolates tested (data not shown). All isolates
were found to be resistant to clarithromycin with MICs of
.16 mg/ml after 14 days of incubation and 5 out of 6 isolates were
resistant to clarithromycin with an MIC of 8 mg/ml from day 5
(Table S1 in File S1). M. bolletii encodes the erythromycin
ribosome methyltransferase (erm) determinant which facilitates
inducible resistance to clarithromycin [35]. The observed resis-
tance from as early as day 5 of reading susceptibility results is
consistent with Patient 1 having received clarithromycin since
2005, with intermittent macrolide treatment prior to that. The
isolates tested demonstrated intermediate resistance to amikacin
and were fully resistant to cefoxitin and ciprofloxacin. Of note, this
patient received treatment with amikacin prior to 2005, which
might explain the reduced sensitivity to this antibiotic. All 3 M.
abscessus spp. type strains demonstrated sensitivity to amikacin
(data not shown). A previous study reported that all M. bolletii
isolates exhibited high drug resistance to ciprofloxacin and
cefoxitin with intermediate resistance or resistance to amikacin
[36]. However M. bolletii isolates susceptible to amikacin and with
intermediate resistance to cefoxitin have also been reported in the
literature [35]. Taken together, these data demonstrate the high
levels of innate in vitro antibiotic resistance among M. bolletii
clinical isolates.
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Genome-wide Examination of M. bolletii Adaptation to
the Human CF Lung
To investigate the molecular adaptation of M. abscessus spp. to
the human lung, we determined the whole genome sequence of 6
sequential isolates of M. bolletii obtained over a 12 year period from
a single persistently infected patient (Table 2). Isolates were
selected to represent the temporal and phenotypic diversity of the
isolates obtained from patient 1 (Table 2). The core genome of the
6 strains, identified as all shared nucleotide sites, was comprised of
4,178,261 sites, and we identified 14,594 variable sites with respect
to the reference genome of M. bolletii type strain CIP108541 [25].
A total number of 34 SNPs (median coverage 21 reads) and 5
nucleotide insertions or deletions were identified as variable within
the core genome among the 6 sequenced genomes (Table 3). A
neighbor-joining tree based on the SNP differences identified
among the 6 isolates consisted of 3 clades with the 2 isolates
obtained in 1998 represented on the same branch (Fig. 3).
However, isolates from different years were more closely related to
each other than to isolates obtained in the same year indicating the
existence of a heterogeneous infecting population containing
multiple persisting sub-lineages (Fig. 3). The diversification of
bacterial pathogens in the CF lung leading to heterogeneous
infecting populations has been previously described for Burkholderia
dolosa, Pseudomonas aeruginosa and Staphylococcus aureus [12,37,38].
Of the 34 SNPs identified among the 6 isolates, 24 gave rise to
non-synonymous mutations (Table 3). Of note, the phoR gene was
affected by 2 distinct non-synonymous mutations in 3 out of the 6
isolates (Table 3; Table S3 in File S2). In Mycobacterium tuberculosis
PhoR is the histidine kinase component of the two-component
system PhoPR involved in the biosynthesis of complex lipids
required for growth of M. tuberculosis inside macrophages and mice
[39]. The occurrence of multiple independent mutations of phoR
implies that phoR attenuation may confer a selective advantage in
the CF lung. In the ED1-4R isolate, a large deletion of the mmpl
gene which encodes Mmpl, a putative membrane protein, was
identified. Deletion of mmpL4b has been demonstrated to result in
a switch from smooth to rough phenotype [40,41] suggesting that
this deletion may be responsible for the rough phenotype of the
isolate. Furthermore, several non-synonymous mutations were
found in genes that are involved in bacterial metabolism, and
regulation of gene expression, leading us to speculate that they
may contribute to the radical transition from a saprophytic to
human pathogenic lifestyle. Finally, the acquisition of amikacin
resistance by M. bolletii relative to the amikacin-sensitive reference
strain led us to examine the genome sequence for the underlying
mutations responsible. Previous studies have demonstrated that
polymorphisms in the 16S rRNA of M. tuberculosis result in
resistance to amikacin [42]. However, there were no polymor-
phisms identified in the 16S rRNA of the amikacin-resistant M.
bolletii isolates, suggesting that an alternative mechanism of
amikacin resistance may exist in M. bolletii.
Concluding Comments
M. abscessus spp. have emerged as an important cause of
pulmonary infection among CF patients with the capacity for
long-term persistence leading to clinical deterioration over time.
Our genetic typing analysis demonstrates the capacity of M.
abscessus spp. isolates to persist for at least 12 years during long-
term infection but also indicates that replacement of M. abscessus
spp. can occur occasionally during long-term infection. The study
provides an indication of the relative prevalence of the 3 M.
abscessus species among a selection of infected patients in Scotland
and reveals that a single globally distributed ST of M. massiliense
(ST23) is also prevalent among Scottish patients. An investigation
into the origin and pathogenic capacity of ST23 is warranted to
understand the basis for the existence of a widespread M. massiliense
clone among infected patients. Finally, the first genome-wide
analysis of the evolution of M. abscessus spp. during long term
infection revealed the heterogeneous nature of the infective M.
bolletii population, and led to the identification of mutations which
may contribute to the adaptation from saprophytic organism to
human pathogen. Characterization of the genetic determinants
involved in the transition of M. abscessus spp. from initial
colonization to severe lung pathology could lead to the identifi-
cation of novel drug targets for the control of M. abscessus spp.
infections.
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